Balloon Valvuloplasty Device Market

Balloon Valvuloplasty Device Market By Type (23mm, 26mm, And 29mm), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of cardiovascular diseases and the increasing demand for minimally invasive treatment approach.

The global balloon valvuloplasty device market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.13% during the forecast period from 2025 to 2032. The demand for balloon valvuloplasty devices is primarily being boosted by the increasing prevalence of cardiovascular diseases such as aortic stenosis, mitral stenosis, and others, surging demand for minimally invasive treatment approaches, growing elderly patients population prone to cardiovascular diseases, increasing prevalence of risk factors, technological advancements in balloon valvuloplasty device, and increasing product launches and approvals, among others, thereby contribute to the overall growth of the balloon valvuloplasty device market during the forecast period from 2025-2032.

Balloon Valvuloplasty Device Market Dynamics:

The increasing prevalence of various cardiovascular diseases such as severe mitral stenosis and others across the globe will increase the overall market of balloon valvuloplasty devices.

For instance, according to the British Heart Foundation 2023, the most common cardiovascular conditions are coronary (ischaemic) heart disease with a prevalence estimated at 200 million, peripheral arterial disease with 110 million cases, stroke with 100 million people, and atrial fibrillation with 60 million cases, in 2019, globally.

Moreover, as per the same source, more than 1.5 million people in the UK aged 65 or over had heart valve disease, including aortic stenosis and mitral regurgitation in 2019. The estimates done by the same sources suggests that the number will double by 2046 and rise to 3.3 million in 2056.

Thus, from the above sources, it can be concluded that the prevalence of cardiovascular diseases is high across various regions worldwide. This in turn will increase the need for balloon valvuloplasty devices used for the treatment or management of cardiovascular diseases, ultimately anticipated to propel the market growth during the forecast period.

Furthermore, the increasing demand and awareness related to minimally invasive treatment approaches for the treatment and management of cardiovascular diseases will in turn create a positive impact on the market in the upcoming years. This is because minimally invasive surgeries over various advantages over open-heart surgeries. People who undergo minimally invasive procedures typically have a shorter recovery time than those who undergo open-heart surgery. Minimally invasive procedures are associated with a lower risk of complications than open-heart surgery.

Therefore, the above-mentioned factors will propel the balloon valvuloplasty device market during the forecast period from 2025-2032.

However, the availability of alternatives in the market, high procedural costs, and others may restrict the growth of the overall balloon valvuloplasty device market.

Balloon Valvuloplasty Device Market Segment Analysis:

Balloon Valvuloplasty Device Market by Type (23mm, 26mm, and 29mm), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the balloon valvuloplasty device market, the 29mm category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with the segment. 

29mm balloon valvuloplasty device devices are medical devices used for the treatment of certain heart conditions called valvular stenosis. 

The 29mm balloon valvuloplasty device is specifically designed for patients who require a larger diameter balloon to dilate their stenotic heart valve.

It is a minimally invasive procedure that involves inserting a deflated balloon catheter into the affected valve through a blood vessel, usually the femoral artery in the groin. The balloon is then inflated to stretch and open the narrowed valve, improving blood flow.

Moreover, usually, the 29mm valvuloplasty device is made up of materials that dissolve over time, leaving no foreign material in the body.

Therefore, owing to the above-mentioned factors, the 29mm category is expected to register significant growth, thereby driving the growth of the overall balloon valvuloplasty device market during the forecast period.

North America is expected to dominate the overall Balloon Valvuloplasty Device Market:

Among all the regions, North America is estimated to account for the largest share of the balloon valvuloplasty device market in the year 2023. Owing to the significance of key growth factors such as the prevalence of cardiovascular diseases, rising demand for minimally invasive treatment approaches, growing elderly patients, rising demand for one-day surgical procedures through ambulatory surgical centers, sophisticated healthcare infrastructure, regulatory approval for new devices, and others, the market for balloon valvuloplasty device is expected to witness prosperity in the region during the forecast period 2025-2032.

The growing prevalence of various cardiovascular diseases is anticipated to increase market growth. For instance, the data provided by the Centre for Disease Control and Prevention (CDC) 2022, it was stated that aortic stenosis is the second most common valvular lesion in the United States. It is present in about 5% of the population at age 65 with increasing prevalence with advancing age. 

Further, the Canadian Cardiovascular Society 2022 report stated that only 3% of Canadians over 60 are aware of aortic stenosis, the most common type of heart valve disease. The same source stated that in 2040 Canada will have an estimated 1.5 million people over 65 with heart valve disease (HVD).

Thus, from the above sources, it can be concluded that the prevalence of cardiovascular diseases is high in the North American region, which in turn will increase the demand for balloon valvuloplasty devices in the region.

Furthermore, the growing elderly population is anticipated to fuel market expansion in this area. For example, according to Statistics Canada statistics released in August 2022, 1,879,862 people in Canada were 70 to 74 years old, whereas 878,672 people were 80 to 84 years old. It is anticipated that the aging population's increased susceptibility to cardiovascular illnesses will fuel demand for cardiac procedures like valvuloplasty propelling the market's expansion in this area.

Thus, the above-mentioned factors are likely to propel the growth of the balloon valvuloplasty device market in the region during the forecast period from 2025-2032.

Key Balloon Valvuloplasty Device Companies In The Market Landscape:

Some of the key balloon valvuloplasty device companies operating in the market include BD, PFM Medical ag, NuMED, Balton, TORAY INDUSTRIES, INC., Translumina, InterValve Medical, Inc., OSYPKA AG, SURETECH MEDICAL INC., simeks, and others.

Recent Developmental Activities in the Balloon Valvuloplasty Device Market:

• In March 2021, Keystone Heart, Ltd., a medical device innovator driven to redefine the standard of structural heart care, entered into an exclusive distribution agreement with InterValve Medical Inc. to sell and market their portfolio of balloon aortic valvuloplasty products, in the United States.

Key Takeaways from the Balloon Valvuloplasty Device Market Report Study

• Market size analysis for current balloon valvuloplasty device market size (2025), and market forecast for 6 years (2025-2032)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key Balloon Valvuloplasty Device companies dominating the global balloon valvuloplasty device market.
• Various opportunities available for the other competitors in the balloon valvuloplasty device market space.
• What are the top-performing segments in 2025? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current balloon valvuloplasty device market scenario?
• Which are the regions and countries where Balloon Valvuloplasty Device companies should have concentrated on opportunities for balloon valvuloplasty device market growth in the coming future?

Target Audience who can be benefited from this Balloon Valvuloplasty Device Market Report Study

• Balloon valvuloplasty device product providers
• Research organizations and consulting companies
• Balloon valvuloplasty device-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in balloon valvuloplasty device
• Various End-users who want to know more about the balloon valvuloplasty device market and the latest technological developments in the balloon valvuloplasty device market.

Frequently Asked Questions for the Balloon Valvuloplasty Device Market:

1. What is a balloon valvuloplasty device?

A balloon valvuloplasty device is a medical device that is used in a minimally invasive procedure called balloon valvuloplasty. The procedure is performed to treat heart valve stenosis, which is a condition where the opening of the heart valve becomes narrow, restricting blood flow. The device consists of a flexible balloon attached to a catheter that is inserted into a blood vessel and guided to the affected valve.

2. What is the market for global balloon valvuloplasty devices?

The global balloon valvuloplasty device market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.13% during the forecast period from 2025 to 2032.

3. What are the drivers for the global balloon valvuloplasty device market?

The demand for balloon valvuloplasty devices is primarily being boosted by the increasing prevalence of cardiovascular diseases such as aortic stenosis, mitral stenosis, and others, surging demand for minimally invasive treatment approaches, growing elderly patients population, technological advancements in balloon valvuloplasty devices, increasing product launches and approvals, and others thereby contributing to the overall growth of the balloon valvuloplasty device market during the forecast period from 2025-2032.

4. Who are the key players operating in the global balloon valvuloplasty device market?

Some of the key market players operating in the balloon valvuloplasty device market include BD, PFM Medical ag, NuMED, Balton, TORAY INDUSTRIES, INC., Translumina, InterValve Medical, Inc., OSYPKA AG, SURETECH MEDICAL INC., simeks, and others.

5. Which region has the highest share in the balloon valvuloplasty device market?

North America is expected to dominate the overall balloon valvuloplasty device market during the forecast period from 2025-2032. Owing to factors such as the rising prevalence of cardiovascular diseases, rising demand for minimally invasive treatment approaches, growing number of elderly patients, rising demand for one-day surgical procedures through ambulatory surgical centers, sophisticated healthcare infrastructure, regulatory approval for new devices, among others, the North America balloon valvuloplasty device market is expected to growth in coming years.